How to use Davercin
Contents of the leaflet
- Package Leaflet: Information for the Patient
- DAVERCIN, 25 mg/g, Gel
- What is Davercin and what is it used for
- Important information before using Davercin
- How to use Davercin
- Possible side effects
- How to store Davercin
- Contents of the pack and other information
Package Leaflet: Information for the Patient
DAVERCIN, 25 mg/g, Gel
Erythromycin cyclocarbonate
Read the package leaflet carefully before using the medicine, as it contains important information for the patient.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. See section 4.
Table of Contents of the Leaflet:
- 1. What is Davercin and what is it used for
- 2. Important information before using Davercin
- 3. How to use Davercin
- 4. Possible side effects
- 5. How to store Davercin
- 6. Contents of the pack and other information
1. What is Davercin and what is it used for
Davercin gel contains as an active substance cyclic 11,12-carbonate of erythromycin A, which belongs to macrolide antibiotics.
Cyclic 11,12-carbonate of erythromycin A acts on some Gram-negative bacteria and many Gram-positive bacteria, including the anaerobic Gram-positive rod Propionibacterium acnes, which is a pathogenic factor in acne.
Davercin applied to intact skin acts locally and is practically not absorbed into the body.
Indications for use
Local treatment of common acne.
2. Important information before using Davercin
When not to use Davercin
Warnings and precautions
- Davercin gel is intended for topical use on the skin only.
- In case of accidental contact of the medicine with the eyes or mucous membranes, these areas should be rinsed with lukewarm water.
- If skin irritation symptoms occur at the application site, you should tell your doctor. The doctor will decide whether to discontinue the medicine.
- The medicine should not be used on damaged skin (cuts, open, weeping wounds).
- Cross-resistance with other macrolide antibiotics may occur.
- The safety and efficacy of the medicine in children have not been established.
Davercin and other medicines
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
Concomitant topical use of other medicines, especially exfoliating and abrasive ones, is not recommended. When using other topical medicines, skin irritation and dryness may occur more frequently.
If concomitant topical treatment is necessary, the other skin medicine should be applied at an interval of several hours.
Pregnancy and breastfeeding
Before taking any medicine, consult your doctor or pharmacist.
If you are pregnant or think you may be pregnant
Davercin should be avoided during pregnancy unless your doctor considers it necessary.
If you are breastfeeding
Your doctor should decide whether to use Davercin gel while breastfeeding.
Driving and using machines
There are no data on the effect of the medicine on the ability to drive and use machines.
Davercin contains propylene glycol
The medicine contains 20 mg of propylene glycol in each gram of gel.
Propylene glycol may cause skin irritation.
Davercin contains dimethyl sulfoxide
The medicine may cause skin irritation.
Davercin contains ethanol
This medicine contains 640 mg of alcohol (ethanol) in each gram of gel.
Due to the ethanol content, the medicine may cause burning of damaged skin.
3. How to use Davercin
The medicine is intended for topical use.
Davercin gel should be applied in a thin layer to the affected areas twice a day - in the morning and in the evening.
The gel should be applied to clean, dry skin.
After each application of the gel, wash your hands thoroughly.
The average treatment period is 6 to 8 weeks.
If you feel that the effect of the medicine is too strong or too weak, consult your doctor.
Using more than the recommended dose of Davercin
Too frequent use of the medicine may cause skin irritation, which usually disappears after discontinuation of the medicine.
In case of accidental ingestion of the medicine, contact your doctor immediately.
Davercin is intended for use on the skin only, not for oral use. In case of accidental ingestion of the medicine, your doctor may recommend gastric lavage. Take the medicine in its original packaging so that the medical staff can check exactly which medicine was used.
If you miss a dose of Davercin
If you miss a dose of the medicine at the fixed, specified time, use it as soon as possible, and then continue the regular use of the medicine.
Do not use a double dose to make up for the missed dose.
4. Possible side effects
Like all medicines, Davercin can cause side effects, although not everybody gets them.
If you experience a severe skin reaction: red, flaky rash with lumps under the skin and blisters (pustular rash), contact your doctor immediately. The frequency of these side effects is unknown (cannot be estimated from the available data).
The following side effects of Davercin gel occur rarely (less than 1 in 1,000 patients).
During prolonged or repeated treatment with erythromycin, resistant bacteria may develop.
Eye irritation has been reported during use of the medicine on the facial skin.
Burning, dryness, itching, flaking, redness, or oiliness of the skin may occur at the application site.
Reporting side effects
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
phone: +48 22 49 21 301; fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
5. How to store Davercin
Keep the medicine out of the sight and reach of children.
Store in a temperature below 25°C.
Do not use this medicine after the expiry date stated on the packaging .
The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
6. Contents of the pack and other information
What Davercin contains
The active substance of the medicine is erythromycin cyclic 11,12-carbonate.
1 g of gel contains 25 mg of erythromycin cyclic 11,12-carbonate.
The other ingredients of the medicine are: dimethyl sulfoxide, propylene glycol, isopropanol, ethanol 96%, hydroxypropyl cellulose.
What Davercin looks like and contents of the pack
Colorless or straw-colored, clear gel.
Packaging:30 g of gel
Marketing authorization holder and manufacturer
Tarchomińskie Zakłady Farmaceutyczne „Polfa” Spółka Akcyjna
ul. A. Fleminga 2
03-176 Warsaw
Phone number: 22 811-18-14Date of last revision of the leaflet:
- Country of registration
- Dosage formGel, 25 mg/g
- ATC codeD10AF02
- Active substance
- Prescription requiredYes
- Manufacturer
- ImporterTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to DavercinDosage form: Ointment, 20 mg/gActive substance: erythromycinManufacturer: Almirall Hermal GmbHPrescription not requiredDosage form: Liquid, 20 mg/gActive substance: erythromycinManufacturer: Almirall Hermal GmbHPrescription requiredDosage form: Liquid, 20 mg/gActive substance: erythromycinPrescription required
Online doctors for Davercin
Discuss questions about Davercin, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Get Davercin Prescription Online
Fill in a 2-min form
Tell us your symptoms, history, and what medicine you're requesting.
Pick a doctor or let us assign
Choose a specialist or we'll match you with the next available doctor.
Doctor reviews your case
Usually within 30 minutes. They may ask follow-up questions via chat.
Collect from any pharmacy
Electronic prescription sent to your email — valid across Spain.
Frequently Asked Questions
Davercin requires a prescription in Poland. You can check with a doctor online whether this medicine may be appropriate for your situation.
The active ingredient in Davercin is erythromycin. This information helps identify medicines with the same composition but different brand names.
Davercin is manufactured by Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Davercin is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.
You can buy Davercin in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.
To obtain a prescription, you can use Oladoctor:
Other medicines with the same active substance (erythromycin) include Aknemicin, Aknemicin, Aknemicin. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.










